A detailed history of Met Life Investment Management, LLC transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 27,685 shares of AVNS stock, worth $445,174. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,685
Previous 27,685 -0.0%
Holding current value
$445,174
Previous $551,000 20.69%
% of portfolio
0.0%
Previous 0.0%

Shares

52 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$17.85 - $20.42 $44,107 - $50,457
2,471 Added 9.8%
27,685 $551,000
Q1 2024

May 14, 2024

BUY
$17.97 - $22.68 $453,095 - $571,853
25,214 New
25,214 $502,000
Q2 2023

Apr 29, 2024

BUY
$22.53 - $30.98 $568,071 - $781,129
25,214 New
25,214 $644,000
Q1 2023

May 09, 2024

BUY
$26.92 - $31.75 $678,760 - $800,544
25,214 New
25,214 $750 Million
Q2 2022

May 10, 2024

SELL
$24.87 - $34.68 $60,384 - $84,203
-2,428 Reduced 8.78%
25,214 $689,000
Q2 2022

Mar 22, 2023

SELL
$24.87 - $34.68 $60,384 - $84,203
-2,428 Reduced 8.78%
25,214 $689,000
Q2 2022

Aug 11, 2022

SELL
$24.87 - $34.68 $60,384 - $84,203
-2,428 Reduced 8.78%
25,214 $689,000
Q1 2022

May 10, 2024

BUY
$28.87 - $35.77 $798,024 - $988,754
27,642 New
27,642 $926,000
Q1 2022

Jun 20, 2023

BUY
$28.87 - $35.77 $70,096 - $86,849
2,428 Added 9.63%
27,642 $926,000
Q1 2022

Mar 22, 2023

BUY
$28.87 - $35.77 $268,808 - $333,054
9,311 Added 50.79%
27,642 $926,000
Q1 2022

May 12, 2022

BUY
$28.87 - $35.77 $268,808 - $333,054
9,311 Added 50.79%
27,642 $926,000
Q4 2021

Jun 21, 2023

SELL
$29.25 - $36.02 $201,327 - $247,925
-6,883 Reduced 27.3%
18,331 $635,000
Q3 2021

Jun 21, 2023

SELL
$31.2 - $38.5 $214,749 - $264,995
-6,883 Reduced 27.3%
18,331 $571,000
Q2 2021

May 17, 2024

SELL
$36.37 - $45.72 $901,066 - $1.13 Million
-24,775 Reduced 57.47%
18,331 $666,000
Q2 2021

Jun 21, 2023

SELL
$36.37 - $45.72 $250,334 - $314,690
-6,883 Reduced 27.3%
18,331 $666,000
Q2 2021

Mar 22, 2023

SELL
$36.37 - $45.72 $901,066 - $1.13 Million
-24,775 Reduced 57.47%
18,331 $666,000
Q2 2021

Aug 16, 2021

SELL
$36.37 - $45.72 $901,066 - $1.13 Million
-24,775 Reduced 57.47%
18,331 $667,000
Q1 2021

May 17, 2024

BUY
$43.5 - $53.4 $778,302 - $955,432
17,892 Added 70.96%
43,106 $1.89 Million
Q1 2021

Jun 26, 2023

BUY
$43.5 - $53.4 $778,302 - $955,432
17,892 Added 70.96%
43,106 $1.89 Billion
Q1 2021

Mar 22, 2023

SELL
$43.5 - $53.4 $172,521 - $211,784
-3,966 Reduced 8.43%
43,106 $1.89 Million
Q1 2021

May 14, 2021

SELL
$43.5 - $53.4 $172,521 - $211,784
-3,966 Reduced 8.43%
43,106 $1.89 Million
Q4 2020

May 24, 2024

SELL
$33.15 - $49.5 $40,144 - $59,944
-1,211 Reduced 2.51%
47,072 $2.16 Million
Q4 2020

Jun 22, 2023

BUY
$33.15 - $49.5 $724,592 - $1.08 Million
21,858 Added 86.69%
47,072 $2.16 Million
Q4 2020

Mar 22, 2023

SELL
$33.15 - $49.5 $40,144 - $59,944
-1,211 Reduced 2.51%
47,072 $2.16 Million
Q4 2020

Feb 16, 2021

SELL
$33.15 - $49.5 $40,144 - $59,944
-1,211 Reduced 2.51%
47,072 $2.16 Million
Q3 2020

May 24, 2024

SELL
$28.67 - $34.32 $27,953 - $33,462
-975 Reduced 1.98%
48,283 $1.6 Billion
Q3 2020

Jun 26, 2023

BUY
$28.67 - $34.32 $661,388 - $791,728
23,069 Added 91.49%
48,283 $1.6 Million
Q3 2020

Mar 22, 2023

SELL
$28.67 - $34.32 $27,953 - $33,462
-975 Reduced 1.98%
48,283 $1.6 Million
Q3 2020

Nov 13, 2020

SELL
$28.67 - $34.32 $27,953 - $33,462
-975 Reduced 1.98%
48,283 $1.6 Million
Q2 2020

May 24, 2024

BUY
$23.48 - $33.86 $564,553 - $814,129
24,044 Added 95.36%
49,258 $1.45 Billion
Q2 2020

Jun 26, 2023

BUY
$23.48 - $33.86 $564,553 - $814,129
24,044 Added 95.36%
49,258 $1.45 Million
Q2 2020

Mar 22, 2023

BUY
$23.48 - $33.86 $19,934 - $28,747
849 Added 1.75%
49,258 $1.45 Million
Q2 2020

Aug 14, 2020

BUY
$23.48 - $33.86 $19,934 - $28,747
849 Added 1.75%
49,258 $1.45 Million
Q1 2020

Jul 12, 2023

BUY
$20.64 - $34.41 $478,744 - $798,139
23,195 Added 91.99%
48,409 $1.3 Million
Q4 2019

Jul 12, 2023

BUY
$31.89 - $47.34 $739,688 - $1.1 Million
23,195 Added 91.99%
48,409 $1.63 Million
Q4 2019

Mar 22, 2023

SELL
$31.89 - $47.34 $7,589 - $11,266
-238 Reduced 0.49%
48,409 $1.63 Million
Q4 2019

Feb 14, 2020

SELL
$31.89 - $47.34 $7,589 - $11,266
-238 Reduced 0.49%
48,409 $1.63 Million
Q3 2019

Jul 12, 2023

BUY
$32.06 - $44.0 $751,261 - $1.03 Million
23,433 Added 92.94%
48,647 $1.82 Million
Q3 2019

Mar 22, 2023

SELL
$32.06 - $44.0 $12,663 - $17,380
-395 Reduced 0.81%
48,647 $1.82 Million
Q3 2019

Nov 14, 2019

SELL
$32.06 - $44.0 $12,663 - $17,380
-395 Reduced 0.81%
48,647 $1.82 Million
Q2 2019

Jul 12, 2023

BUY
$37.68 - $46.52 $897,839 - $1.11 Million
23,828 Added 94.5%
49,042 $2.14 Million
Q2 2019

Mar 22, 2023

SELL
$37.68 - $46.52 $27,016 - $33,354
-717 Reduced 1.44%
49,042 $2.14 Million
Q2 2019

Aug 14, 2019

SELL
$37.68 - $46.52 $27,016 - $33,354
-717 Reduced 1.44%
49,042 $2.14 Million
Q1 2019

Jul 13, 2023

BUY
$39.84 - $51.04 $977,872 - $1.25 Million
24,545 Added 97.35%
49,759 $2.12 Million
Q1 2019

Mar 22, 2023

BUY
$39.84 - $51.04 $239 - $306
6 Added 0.01%
49,759 $2.12 Million
Q1 2019

May 15, 2019

BUY
$39.84 - $51.04 $239 - $306
6 Added 0.01%
49,759 $2.12 Million
Q4 2018

Jul 13, 2023

BUY
$41.16 - $66.67 $1.01 Million - $1.64 Million
24,539 Added 97.32%
49,753 $2.23 Million
Q4 2018

Mar 22, 2023

SELL
$41.16 - $66.67 $485,194 - $785,905
-11,788 Reduced 19.15%
49,753 $2.23 Million
Q4 2018

Feb 14, 2019

SELL
$41.16 - $66.67 $485,194 - $785,905
-11,788 Reduced 19.15%
49,753 $2.23 Million
Q3 2018

Jul 13, 2023

BUY
$55.13 - $72.65 $1.35 Million - $1.78 Million
24,566 Added 97.43%
49,780 $3.41 Million
Q3 2018

Mar 22, 2023

BUY
$55.13 - $72.65 $2 Million - $2.64 Million
36,327 Added 144.07%
61,541 $4.22 Million
Q3 2018

Nov 14, 2018

BUY
$55.13 - $72.65 $3.39 Million - $4.47 Million
61,541 New
61,541 $4.22 Million

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $748M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.